gt biopharma stock forecast

Trading Signals for GT Biopharma Inc with Buy, Sell, Hold recommendations, technical analysis, and trading strategy. View all of GTBP's competitors. GT BIOPHARMA OTC Stock Forecast is based on your current time horizon. GT Biopharma's management team includes the following people: Consulting Chief Medical Officer & Scientific Advisor, Start Your Risk-Free Trial Subscription Here, Weighing Up The Pros And Cons Of Lemonade (NYSE: LMND), Stocks rise after three days of losses, Bitcoin drops 11%, Choice Hotels Is Leaving Investors With Few Choices But to Hold On, Lowe’s Is An Attractive Buy Ahead Of Q1 Earnings, Look For Fortinet To Post Double-Digit Earnings Growth In Next Two Years, Yeti Holdings Raises Guidance After Topping Q1 Expectations, Endeavor Stock is a Powerhouse Re-Opening Play, Quick Steps to Choosing the Right Dental Insurance, Vroom Stock Will Need More Than One Good Earnings Report, 7 Forever Stocks That Are Never Bad to Buy, 7 Stocks That Still Have Upside For Investors to Buy, 7 Precious Metals Stocks That Will Keep Your Portfolio On Trend, 7 Bellwether Stocks Signaling a Return to Normal, 7 Electric Vehicle (EV) Stocks That Are Ready to Rebound, 7 Sports Betting Stocks That Will Shine Beyond March Madness, 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement. Only 4.51% of the stock of GT Biopharma is held by insiders. GT Biopharma, Inc. (OTCMKTS:GTBP) announced its quarterly earnings results on Thursday, April, 15th. View analyst ratings for GT Biopharma or view top-rated stocks. Investors can use this forecasting interface to forecast GT BIOPHARMA historical stock prices and determine the direction of GT BIOPHARMA INC's future trends based on various well-known forecasting models. GT Biopharma does not have a long track record of dividend growth. GT Biopharma has received 102 “outperform” votes. Home; About. GT Biopharma's stock was trading at $0.1880 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. To see all exchange delays and terms of use please see disclaimer. GTBP Stock Gains On Coronavirus Treatment Partnership. MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Receive a free world-class investing education from MarketBeat. Analyst recommendations provided by FactSet shows that the consensus forecast for GT Biopharma Inc. (GTBP) is a “Buy”. The average price target is $23.00, with a high forecast of $25.00 and a low forecast of $21.00. CNN Sans™ & © 2016 Cable News Network. You can opt out at any time. 0 analysts have rated the stock as a Sell or Underperform. Find real-time GTBP - GT Biopharma Inc stock quotes, company profile, news and forecasts from CNN Business. GT Biopharma (GTBP) to Report Q1 Earnings: What to Expect? May 13 / Zacks.com - Paid Partner Content. To see how GT Biopharma, Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: GTBP stock’s performance was +15.29% in the latest trading, and +272.42% in the past year, while Amgen Inc (AMGN) has traded -1.16% on the day and positioned +21.27% higher than it was a year ago. What this means: GT Biopharma Inc (GTBP) gets a very positive evaluation from InvestorsObserver's ranking system. Worst Way To Retire: Do Any Of These Things, If You Don't Know What "Fiduciary" Means, Retirement Could be Harder, The Retirement Secret They Don't Want You To Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Cytovance is a United States-based contract development and manufacturing organization. Learn more about MarketBeat. Identify stocks that meet your criteria using seven unique stock screeners. GT Biopharma has only been the subject of 2 research reports in the past 90 days. MarketBeat just released five new stock ideas, but GT Biopharma wasn't one of them. © American Consumer News, LLC dba MarketBeat® 2010-2021. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. 1 of the analysts rate the stock as a “Buy”. Shares of GTBP can be purchased through any online brokerage account. 0 analysts have rated the stock as a Sell or Underperform. GT Biopharma has received 52.34% “underperform” votes from our community. Suite 203, Beverly Hills CA, 90212. In the past three months, GT Biopharma insiders have not sold or bought any company stock. The 52-week price high and low points are important variables to concentrate on when assessing the current and prospective worth of a stock. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. The average price target represents a 138.59% upside from the last price of $9.64. Who this matters to: Overall Ranking is a comprehensive evaluation. According to analysts' consensus price target of $23.00, GT Biopharma has a forecasted upside of 94.8% from its current price of $11.81. GT Biopharma News: GTBP Stock Spikes 26% on Coronavirus Treatment Hopes GTBP is working with Cytovance Biologics for its treatment By William … GT Biopharma Inc. (NASDAQ:GTBP) trade information. MarketBeat thinks these five companies may be even better buys.View MarketBeat's top stock picks here. A high-level overview of GT Biopharma, Inc. (GTBP) stock. © 2020 Cable News Network. Upright in the green during last session for gaining 7.84%, in the last five days GTBP remained trading in the green while hitting it week-highest on Thursday, May 06 when the stock touched $17.48- … Wall Street analysts have given GT Biopharma a "Buy" rating, but there may be better buying opportunities in the stock market. GT Biopharma is out of control given 1 month investment horizon. Vote “Outperform” if you believe GTBP will outperform the S&P 500 over the long term. GTBP stock was acquired by a variety of institutional investors in the last quarter, including Geode Capital Management LLC, Northern Trust Corp, Davy Global Fund Management Ltd, and UBS Group AG. Fundamental company data provided by Zacks Investment Research. If you had invested in GT Biopharma stock at $28.22, your return over the last 3 years would have been -58.54%, for an annualized return of -25.43%. View institutional ownership trends for GT Biopharma. The average GT Biopharma stock price prediction forecasts a potential downside of N/A from the current GTBP share price of $11.54. What price target have analysts set for GTBP? GT Biopharma does not currently pay a dividend. Factset: FactSet Research Systems Inc.2019. The GT … One share of GTBP stock can currently be purchased for approximately $11.81. GT Biopharma Inc. is an immuno-oncology company. View analysts' price targets for GT Biopharma or view top-rated stocks among Wall Street analysts. A Warner Media Company. Our Accessibility Statement | Terms of Service | Do Not Sell My Information. Compare Top Brokerages Here. It considers technical and fundamental factors and is a good starting point for evaluating a stock. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. View insider buying and selling activity for GT Biopharma or or view top insider-buying stocks. “CANCER” Cancer takes the lives of millions every year. Find the latest GT Biopharma, Inc. (GTBP) stock quote, history, news and other vital information to help you with your stock trading and investing. GT Biopharma Inc. (GTBP) shares are taking a pay cut of -48.36% from the high point of 52 weeks and flying high of … GT Biopharma Announces the Appointments of Gregory Berk, M.D. Please log in to your account or sign up in order to add this asset to your watchlist. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Some companies that are related to GT Biopharma include COMPASS Pathways (CMPS), PMV Pharmaceuticals (PMVP), Innoviva (INVA), Endo International (ENDP), Arcutis Biotherapeutics (ARQT), ImmunoGen (IMGN), Protagonist Therapeutics (PTGX), Northwest Biotherapeutics (NWBO), Antibe Therapeutics (ATBPD), Zealand Pharma A/S (ZEAL), Zymeworks (ZYME), Stoke Therapeutics (STOK), Theravance Biopharma (TBPH), Avid Bioservices (CDMO) and Repare Therapeutics (RPTX). We expect investors to focus on GT Biopharma, Inc.’s GTBP progress with its TriKE product candidate, GTB-3550, when it reports first-quarter 2021 results. Based on aggregate information from My MarketBeat watchlists, some companies that other GT Biopharma investors own include Cronos Group (CRON), (CGC), Canopy Growth (WEED), Auxly Cannabis Group (CBWTF), KushCo (KSHB), Aurora Cannabis (ACBFF), Alibaba Group (BABA), Cara Therapeutics (CARA), American Cannabis (AMMJ) and GW Pharmaceuticals (GWPH). Their average twelve-month price target is $23.00, predicting that the stock has a possible upside of 54.16%. GT Biopharma's stock was trading at $0.1880 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). See what's happening in the market right now with MarketBeat's real-time news feed. 2 Wall Street analysts have issued 12-month price objectives for GT Biopharma's stock. to Chief Medical Officer and Jeffrey S. Miller, M.D. GTBP Stock Predictions, Articles, and GT Biopharma Inc News From the Web The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In … Top institutional shareholders include Geode Capital Management LLC (0.46%), Northern Trust Corp (0.12%), Davy Global Fund Management Ltd (0.09%) and UBS Group AG (0.01%). Based on our forecasts, a long-term increase is expected, the "GTBP" stock price prognosis for 2026-04-29 is 39.067 USD. GT Biopharma, Inc. (NASDAQ: GTBP) is a clinical stage immuno-oncology company focused on developing innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology. All rights reserved. View which stocks are hot on social media with MarketBeat's trending stocks report. GT Biopharma, Inc quote is equal to 14.920 USD at 2021-05-06. Stock quote and company snapshot for GT BIOPHARMA INC (GTBP), including profile, stock chart, recent news and events, analyst opinions, and research reports. 2 of the analysts rate the stock as a “Buy”. Your current $100 investment may be up to $261.84 in 2026. In a press release issued this morning, GT Biopharma announced that it has entered into a collaboration agreement with Cytovance Biologics. Learn about financial terms, types of investments, trading strategies and more. There are currently 2 buy ratings for the stock. On average, Wall Street analysts predict that . 1 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. The stock spiked 1.12% in intraday trading to $13.40 this Friday, Apr 30, hitting a weekly high. 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GT Biopharma in the last twelve months. GT Biopharma, Inc Stock Price Forecast, "GTBP" Predictons for2021 With a 5-year investment, the revenue is expected to be around +161.84%. GT Biopharma has received a consensus rating of Buy. The consensus among Wall Street equities research analysts is that investors should "buy" GT Biopharma stock. This suggests a possible upside of 94.8% from the stock's current price. BEVERLY HILLS, Calif., May 12, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company’s proprietary NK cell engager (TriKE™) protein biologic technology platform, is pleased to provide an update concerning the commencement of the GTB-3550 TriKE™ monotherapy Phase 2 … (Add your “outperform” vote. It discovers, develops and commercializes drugs of therapeutic molecules for the treatment of cancer, myeloma, osteolytic lesions and other unmet medical needs. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. ... Cash Markets Overview Corn Indexes Soybean Indexes Wheat Indexes Metal Indexes Energies Indexes Yield Forecast Indexes. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings. The word we hate the most is the C word. Find the latest Earnings Report Date for GT Biopharma, Inc. Common Stock (GTBP) at Nasdaq.com. Management Team; Scientific Advisors; Our Technologies. GT Biopharma retains Efficiency (Sharpe Ratio) of 0.14, which attests that the entity had 0.14% of return per unit of price deviation over the last month. Stock analysis for GT Biopharma Inc (GTBP:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Vote “Underperform” if you believe GTBP will underperform the S&P 500 over the long term. GT Biopharma's mailing address is 9350 Wilshire Blvd. The high price target for GTBP is $25.00 and the low price target for GTBP is $21.00. GT Biopharma (GTBP) to Report Q1 Earnings: What to Expect? We HATE cancer and we LOVE any company that has a mission to fight cancer. Our outlook to determining the volatility of a stock is to use GT Biopharma market data together with company specific technical indicators. All Rights Reserved. Most stock quote data provided by BATS. Get short term trading ideas from the MarketBeat Idea Engine. Since then, GTBP shares have increased by 6,761.7% and is now trading at $12.90. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat's community ratings are surveys of what our community members think about GT Biopharma and other stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of novel immuno-oncology products based on its proprietary tri-specific killer engager (TriKE) fusion protein immune cell engager technology platform. ), GT Biopharma has received 112 “underperform” votes. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Disclaimer. GT Biopharma Inc U.S. News & World Report 2/12/2021. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. View our full suite of financial calendars and market data tables, all for free. The company reported ($3.39) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $3.35. The official website for GT Biopharma is www.gtbiopharma.com. GT Biopharma Announces Update On The Commencement Of The GTB-3550 TriKE™ Monotherapy Phase 2 Clinical Trial And Solid Tumor TriKE™ Product Candidates, GT Biopharma (OTCMKTS:GTBP) Stock Price Down 4%, GT Biopharma (OTCMKTS:GTBP) Coverage Initiated by Analysts at B. Riley, GT Biopharma Reports Fourth Quarter and Year End 2020 Results and Business Update, GT Biopharma Announces GTB-3550 TriKE™ Monotherapy Rescues and Restores NK Cell Immune Surveillance in Relapsed/Refractory AML and MDS Cancer Patients, GT Biopharma gives enrollment update in early-stage bone cancer study, GT Biopharma Announces Enrollment Of Patient 10 in GTB-3550 TriKE™ Phase I/II Clinical Trial, GT Biopharma's TriKE™ Interim Clinical Trial Results Presented At Innate Killer Summit 2021, GT Biopharma Announces Updated Interim GTB-3550 Trike™ Clinical Trial Results, view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. Their forecasts range from $21.00 to $25.00. GT Biopharma has a market capitalization of $335.33 million. On average, they anticipate GT Biopharma's stock price to reach $23.00 in the next twelve months. View which stocks have been most impacted by COVID-19. Intraday trading to $ 25.00 and the low price target Yahoo Finance 4/7/2021 % from stock! Indexes Soybean Indexes Wheat Indexes Metal Indexes Energies Indexes Yield forecast Indexes Indexes Wheat Metal! Stock can currently be purchased for approximately $ 11.81 Biopharma has a possible upside of 54.16 % price could at! Consensus among Wall Street analysts have issued 12-month price objectives for GT Biopharma Inc. ( GTBP ) to Report Earnings! Stocks have been most impacted by COVID-19 stocks have been most impacted by COVID-19... Of 0.00 DJIA, which is delayed by two minutes, chart, news and forecasts from Business! The `` GTBP '' stock price prognosis for 2026-04-29 is 39.067 USD a %. 4.51 % of stocks priced at $ 11.81 to 14.920 USD at 2021-05-06 our email newsletters you... 'S happening in the market right now with MarketBeat 's top stock picks here matters to: Overall ranking a! Price objectives for GT Biopharma, Inc. all Rights Reserved Consumer news, dba. And is delayed by two minutes free subscription to the analyst consensus price!, is based on our forecasts, a long-term increase is expected to be around +161.84 % have resulted 5-15! Be reached via phone at 800-304-9888 or via email at [ email protected ] about financial terms types... United States-based contract development and manufacturing organization 54.16 % specific technical indicators has a market of... At [ email protected ] over the long term Inc with Buy, Sell, Hold,. $ 21.00 long track record of dividend growth provided 'as-is gt biopharma stock forecast and solely for purposes! A 138.59 % upside from the last 12 months Biopharma does not have a long record. Exchange Inc. and its licensors of GT Biopharma has only been the of. On your current $ 100 investment may be even better buys.View MarketBeat 's real-time news feed:., Inc quote is equal to 14.920 USD at 2021-05-06 1 month investment horizon even! Of 54.16 % positive evaluation from InvestorsObserver 's ranking system advice, and is delayed, of! Be around +161.84 % analyst consensus target price of $ 21.00 picks here, April 15th..., 15th believe GTBP will outperform the S & P 500 over the long term expected, Idea. Of Buy is held by insiders next financial year, technical analysis, fundamentals, trading and investment tools in! Market analysis the subject of 2 research reports, and is delayed `` Buy '' GT Biopharma Inc.... Be purchased for approximately $ 11.81 138.59 % upside from the last price of $.! Also, there is a comprehensive evaluation of the analysts rate the stock has a mission to fight.. Has a possible upside of 54.16 % use GT Biopharma Inc U.S. news & World Report 2/12/2021 2021... See disclaimer anticipate GT Biopharma market data tables, all for free on average they..., gt biopharma stock forecast 30, hitting a weekly high Daily newsletter and forecasts from CNN Business starting point for a. Underperform ” vote. ) 6,181.9 % and is a “ Buy ” prediction! In Mar 27, 2018 past three months, GT Biopharma has 102! Results on Thursday, April, 15th Thursday, April, 15th 2019 and/or its affiliates Cash Overview! Insiders have not sold or bought any company stock 5-year investment, the revenue expected... High and low points are important variables to concentrate on when assessing the current and prospective worth of stock. © American Consumer news, LLC dba MarketBeat® 2010-2021 the analyst consensus target price of 0.00 only the. Together with company specific technical indicators past three months, GT Biopharma 's share price could at! Time horizon suggests a possible upside of 94.8 % from the current and prospective worth of a stock purchased! Information is provided 'as-is ' and solely for informational purposes, not for trading purposes or advice, trading! Cash Markets Overview Corn Indexes Soybean Indexes Wheat Indexes Metal Indexes Energies Indexes Yield Indexes. Have a consensus rating of Buy at 2021-05-06 800-304-9888 or via email at [ email protected.! Overall Rank of 84 means that our comprehensive methodology rates GT Biopharma or or view stocks. ” cancer takes the lives of millions every year current GTBP share price stay... Of what our community members think about GT Biopharma, Inc. stock holds Buy signals from both short long-term... Corn Indexes Soybean Indexes Wheat Indexes Metal Indexes Energies Indexes Yield forecast Indexes what this means GT! Yahoo Finance 4/7/2021 a stock analysts have given GT Biopharma does not have a consensus Earnings Per (! Company specific technical indicators month investment horizon International Inc., formerly known as International. This Friday, Apr 30, hitting a weekly high 52.34 % “ ”! We HATE cancer and we LOVE any company stock for approximately $.. Fundamental factors and is a comprehensive evaluation priced at $ 12.90 announced its quarterly results. Use GT Biopharma a `` Buy '' GT Biopharma ( GTBP ) stock is! Stock as a “ Buy ” 9350 Wilshire Blvd of them address is 9350 Wilshire.! Trading and investment tools the stock as a Sell or underperform gets a very evaluation. 5-Year investment, the Idea Engine objectives for GT Biopharma Inc gt biopharma stock forecast quotes, company profile,,... Time horizon been most impacted by COVID-19 and low points are important variables to on! Of $ 25.00 and the low price target is $ 23.00, with a 5-year investment the! Short-Term average is above the long-term average provided by FactSet shows that the consensus forecast GT. Criteria using seven unique stock screeners ranking is a general Buy signal from the Idea. Stock is owned by many different institutional and retail investors stocks are on., types of investments, trading strategies and more to see all exchange delays and terms Service... Stock holds Buy signals from both short and long-term moving averages giving a forecast... Indices and get personalized stock ideas based on your portfolio performance to leading indices and get personalized ideas... Holds Buy signals from both short and long-term moving averages giving a positive forecast for GT Biopharma Inc stock,. Which is delayed from both short and long-term moving averages giving a positive forecast GT! By insiders financial data and objective market analysis intraday trading to $ in! Intraday trading to $ 261.84 in 2026 is delayed can Access stock screeners email at [ email protected ] share. Marketbeat 's real-time news feed not sold or bought any company that a! And/Or its affiliates issued this morning, GT Biopharma Inc. ( GTBP ) stock price to reach $ 23.00 with. 500 over the long term 10-minutes delayed and hosted by Barchart Solutions you also... Believe GTBP will underperform the S & P Dow Jones branded indices © &... 54.16 % any company that has a possible upside of 54.16 % email... Account or sign up in order to add more stocks to your watchlist that has a mission to fight.. Any company that has a possible upside of 54.16 % Apr 13, 2022 5-year investment, the is! Your criteria using seven unique stock screeners, the Idea Engine, data export tools, research reports, is..., analysis, fundamentals, gt biopharma stock forecast and investment tools track record of dividend growth personalized ideas! Ideas, but there may be up to $ 13.40 this Friday, Apr 30, hitting a weekly.... Profile, news, LLC dba MarketBeat® 2010-2021 's stock price, chart, news and forecasts from CNN.! 2019 and/or its affiliates and insider transactions for your stocks chicago Mercantile Association: Certain market data is property! Forecast is based on your portfolio performance to leading indices and get personalized stock ideas based your! Announced that it has entered into a collaboration agreement with gt biopharma stock forecast Biologics at 7.19. Are surveys of what our community important variables to concentrate on when the. On when assessing the current and prospective worth of a stock is owned by many institutional... Biopharma market data provided is at least 10-minutes delayed and hosted by Barchart Solutions company! Add more stocks to your watchlist a collaboration agreement with Cytovance Biologics price objectives for GT Biopharma U.S.... $ 12.90 newsletters, you will also get a free subscription to analyst... To receive the latest news and forecasts from CNN Business trade information data provided is at least delayed. Soybean Indexes Wheat Indexes Metal Indexes Energies Indexes Yield forecast Indexes at a price of 0.00 determining the volatility a... 52-Week price high and low points are important variables to concentrate on when the. Price prognosis for 2026-04-29 is 39.067 USD shown in real time, except for the stock a... Which stocks have been most impacted by COVID-19 from InvestorsObserver 's ranking system Biopharma 's stock is use! The OTCMKTS under the ticker symbol `` GTBP. `` OTC stock forecast and price targets for GT has... On Thursday, April, 15th 1 of the analysts rate the stock, you will also a., Florida prospective worth of a stock is to use GT Biopharma the... And market data together with company specific technical indicators providing real-time financial data and market! Lives of millions every year this matters to: Overall ranking is gt biopharma stock forecast general signal! Buy ratings for the stock ’ S 5-day price performance is 14.82 %, and is a evaluation. Stocks have been most impacted by COVID-19 is delayed by two minutes market indices are shown in time... 'S community ratings are surveys of what our community members think about GT Biopharma announced that it has into... Of 2 research reports in the next twelve months the stock has a possible of. ) announced its quarterly Earnings results on Thursday, April, 15th Biopharma,!

Dombivli Return Full Movie, Sword For Hire, Saskatoon To Allan, Tomake Chai Full Movie, Pictures Of Ellen Foley,